Key facts
- Bioplastix’s last known valuation is $5.0M (Dec 2025).
- It has raised $280K; the latest was Seed Round in Jan 2026.
- Notable investors include Start-Up Chile, Grid Exponential, CATAL1.5T.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Bioplastix
- ·The full record, as it builds
Funding rounds
No funding rounds for Bioplastix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bioplastix
Developer of genome-engineered biopolymer production technology designed to enable cost-efficient and scalable biodegradable materials. The company's technology integrates artificial intelligence-driven strain optimization, precision fermentation, and customized biopolymer formulation, enabling industrial partners to produce performance bioplastics from low-cost feedstocks with tailored material properties and improved sustainability outcomes.
- Sector
- Materials and Resources
- HQ
- Buenos Aires, Argentina
- Founded
- 2024
- Employees
- 7
- Website
- bio-plastix.com/
- Ownership
- Privately Held (backing)
Bioplastix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bioplastix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bioplastix in its N-PORT filings yet. We sweep new filings monthly.